PARKD strikes key licencing deal for construction technology
PARKD (ASX: PKD) has sealed an exclusive licencing agreement with Fielders Steel Roofing – a division of BlueScope Steel – for the group’s intellectual property (IP) rights connected to its metal decking support bracket (MDSB) and metal deck support system (MDSS) used in the construction of car parks and other commercial structures. More specifically, PARKD […]
OZM, 1TT, EQR, CVB, NUZ, VTX, WNX, EUR & PDI
What’s Hot, Not & Doing Brought to you by TSN Contributor & Wealth Advisor Nick Kelso What’s Hot – OZM, 1TT, EQR, CVB, NUZ, VTX, WNX, EUR & PDI What’s Not – MGU What’s Hot OZM – OzAurum Limited today closed up 62% to finish at 10.5c on $3.7m stock traded. The reason they were […]
OSL, GDM, BB1, MM1, MM8, WA1 & WTM
What’s Hot, Not & Doing Brought to you by TSN Contributor & Wealth Advisor Nick Kelso What’s Hot – OSL, GDM, BB1, MM1, MM8, WA1 & WTM What’s Not – XF1 & BM8 What’s Hot OSL – OncoSil Medical Limited today closed up 40% to finish at 0.7c on $140k stock traded. The reason they […]
Findi set for financial boost with ATM rollout in India
Digital payments and financial services provider Findi Limited (ASX: FND) has locked in a deal with Union Bank of India (UBI) for the deployment of an additional 900 ATMs across India through its majority owned subsidiary company, Transaction Solutions International (TSI). Financial boost The seven year agreement is expected to deliver between $75 million and […]
Vection lands major defence contract as AI momentum grows
Vection Technologies (ASX: VR1), a specialist in immersive and extended reality (XR) solutions, has nailed down a $4 million contract extension with an existing client in the defence sector. The agreement follows two other recent contract wins with the same customer. The broadened agreement relates to large-scale, distributed infrastructure design which enables real-time data processing […]
Argenica’s flagship drug shows reduced brain injury in study
A study testing the efficacy of Argenica Therapeutics’ (ASX: AGN) leading drug known as ARG-007 has displayed significant neuroprotection in traumatic brain injury (TBI). More specifically, the broadened pre-clinical rat study measuring axonal injury and neuroinflammation following TBI has shown ARG-007 to significantly reduce damage to brain cells. Multiple positive outcomes Management noted that axonal […]
dorsaVi partners with guru surgeon for athlete movement study
Motion analysis device specialist dorsaVi (ASX: DVL) has entered a commercial research project with heralded American physician Dr Chiarg Patel that will explore innovative assessment techniques for ankles and feet during sporting events and training. More specifically, the study aims to uncover patterns and traits that could increase the risk of injury in elite athletes. […]
Experience Co builds momentum as earnings and revenue jump
Adventure tourism specialist Experience Co (ASX: EXP) has served up a strong set of numbers for the second quarter of the 2025 financial year (FY25), showcased by solid revenue growth across both its operating segments and improved earnings stemming from cost optimisation initiatives. Revenue growth on rising volume In total, revenue of $37.2 million for […]
EVR, RHK, ASO, DSE, AQD, TRI & TM1
What’s Hot, Not & Doing Brought to you by TSN Contributor & Wealth Advisor Nick Kelso What’s Hot – EVR, RHK, ASO, DSE, AQD, TRI & TM1 What’s Not – LOT What’s Hot EVR – EV Resources Limited today closed up 60% to finish at 0.4c on $170k stock traded. The reason they were up […]
EBR Systems Inc (ASX:EBR): Developing the world’s only leadless pacemaker for heart failure
Shares in EBR Systems Inc (ASX:EBR) are up more than 100% over the last year as the company continues to revolutionise cardiac rhythm management with its wireless WiSE CRT System used to treat heart rhythm diseases. Ahead of appearing at Wholesale Investors’ Emergence 2025 event Andrew Shute, Senior Vice President of Business Development at EBR […]